Clinical Trials Directory

Trials / Completed

CompletedNCT02067962

Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
1 Month – 40 Years
Healthy volunteers
Not accepted

Summary

Juvenile idiopathic arthritis (JIA) is considered to be a multifactorial disease caused by a combination of environmental factors and predisposing genetic factors. Twins studies found a strong heritability (strong genetic factors) but genetic studies such association studies of large cohorts of patient (GWAS or Genome Wide Association Study) have elucidated less than 20 % of the genetic basis of JIA. The vision of the genetics of multifactorial diseases has recently changed revealing a large clinical and genetic heterogeneity of these diseases. Indeed, the advent of next-generation sequencing identified non-multifactorial genetic hereditary disease related to mutations in genes having strong effect on the onset of the disease without real impact of environmental factors among the so called "multifactorial diseases" (Parkinson's, diabetes, osteoarthritis, Alzheimer's, hypertension ...)The investigators propose to study 30 families with several forms of JIA by next-generation sequencing. Identifying the genetic basis of JIA in these families will help to better understand the physiopathology of this disease and may help to the identification of novel therapeutic targets for other patients with JIA.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sampleBlood sample

Timeline

Start date
2014-03-05
Primary completion
2014-09-24
Completion
2015-06-24
First posted
2014-02-20
Last updated
2020-03-17

Source: ClinicalTrials.gov record NCT02067962. Inclusion in this directory is not an endorsement.